Institutional investors hold a majority ownership of ACT through the 62.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2014, these large investors purchased a net $14.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE TEACHERS RETIREMENT SYSTEM... Bought 314.8 Thousand shares of Actavis PLC
STRATEGIC ADVISERS, INC. Bought 153.9 Thousand shares of Actavis PLC
JACKSON SQUARE PARTNERS LLC Bought 102.8 Thousand shares of Actavis PLC